Entera Bio Ltd. ENTX
3.20 USD -0.02 (-0.62%)
Nov 12, 2026, 1:52 PM EST
3.13 Day range 3.24
0.91 52-week range 4.20
- YTD
- +64.95%
- 1 year
- +9.97%
ENTX revenue history
Revenue is income from the company’s ordinary business activities.
42,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 42,000 | -139,000 | -76.80% |
| FY 2024 | 2024-12-31 | 181,000 | 181,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | -134,000 | -100.00% |
| FY 2022 | 2022-12-31 | 134,000 | -437,000 | -76.53% |
| FY 2021 | 2021-12-31 | 571,000 | 206,000 | 56.44% |
| FY 2020 | 2020-12-31 | 365,000 | 129,000 | 54.66% |
| FY 2019 | 2019-12-31 | 236,000 | -264,000 | -52.80% |
| FY 2018 | 2018-12-31 | 500,000 | 500,000 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:51.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.